32 papers
Primary care research focuses on the everyday health challenges faced by communities, bridging the gap between specialized medical knowledge and the doctors who treat patients in local clinics. This field explores how to prevent illness, manage chronic conditions, and improve patient outcomes directly where people seek help. On Gist.Science, we make these vital studies easier to understand by breaking down complex findings into clear, actionable insights for everyone.
Every new preprint in this category comes directly from medRxiv, the leading repository for health sciences research. Our team processes each fresh submission to provide both a simple, plain-language overview and a detailed technical summary, ensuring you grasp the full context without getting lost in jargon. Below are the latest papers in primary care research, freshly summarized and ready for your review.
Based on data from 1,028 adults, the TIMES survey reveals that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome imposes a severe, multi-system symptom burden characterized by universal fatigue and cognitive issues, with women experiencing a greater overall burden than men.
This study reveals that physically disabled women in the UK face significant barriers to cervical screening, primarily due to disability-specific factors like pain and embarrassment, and highlights the critical need for healthcare provider training to ensure equitable access.
This study demonstrates the feasibility of creating a reusable archive of UK primary care telephone consultations linked to electronic health records and patient questionnaires, though it highlights low consent rates—particularly in deprived areas—when using retrospective remote recruitment methods.
Despite the willingness of nurses and pharmacists to support hypertension management in Australia, team-based care remains largely unrealized due to systemic barriers such as inadequate funding, fragmented communication, and role ambiguity that perpetuate a predominantly GP-centered model.
This mixed-methods study in Dutch general practices evaluated an intervention combining a cardiovascular expert team and a self-management toolbox for hypertension, finding the expert support valuable (particularly for nurse practitioners) while identifying the toolbox as challenging to use and concluding that structured implementation strategies are needed to optimize care.
A 2025 questionnaire survey of Danish pharmacy technicians revealed that while most are aware of the teratogenic risks of oral retinoids, knowledge regarding valproate is significantly poorer, with many lacking familiarity with the required Pregnancy Prevention Program measures, highlighting an urgent need for targeted educational interventions.
A cluster-randomised trial demonstrates that clinicians using a GenAI-based clinical decision support tool significantly reduced critical and potential risks in their decisions over time, suggesting such systems could evolve from mere safety checkers into transformative investments for strengthening healthcare systems through continuous learning.
A 2022 UK study of social workers reveals that while they view social prescribing as a valuable resource for addressing low-level needs, they simultaneously express significant concerns regarding contested professional boundaries and the potential for the initiative to encroach upon or undermine the complexity of social work practice.
This cross-sectional study of 431 healthcare professionals in Uttarakhand reveals that while awareness of sugar-free paediatric liquid medicines is high, critical gaps exist in recognizing their link to dental caries and providing oral health advice, with prescribing practices hindered by concerns over cost, palatability, and availability.
This paper proposes that monitoring serial serum creatinine levels relative to an individual's historical maximum is a more reliable and practical method than estimated GFR equations for detecting early glomerular filtration rate decline above 60 mL/min, enabling earlier intervention before chronic kidney disease stage 3.